Comfort, self-confidence, safety, and dopamine D2 receptor occupancy by antipsychotics [5]

American Journal of Psychiatry

Volumn 162, Issue 8, 2005, Pages 1544-1545

  De Haan, Lieuwe ^a   Lavalaye, Jules ^a   Booij, Jan ^a   Linszen, Don ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; DOPAMINE 2 RECEPTOR; NEUROLEPTIC AGENT;

DYSPHORIA; EXPERIENCE; LETTER; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; RECEPTOR OCCUPANCY; SAFETY; WELLBEING;

ADULT; ANTIPSYCHOTIC AGENTS; BENZAMIDES; FEMALE; HUMANS; MALE; PERSONAL SATISFACTION; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; PYRROLIDINES; RECEPTORS, DOPAMINE D2; SAFETY; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF EFFICACY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 23344445690     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.162.8.1544     Document Type: Letter

References (4)

1. 2 occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry 2000; 157:514-520
2. de Haan L, Lavalaye J, Linszen D, Dingemans PMAJ, Booij J: Subjective experience and striatal dopamine D2 receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone. Am J Psychiatry 2000; 157:1019-1020
3. 2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study. Am J Psychiatry 2003; 160:303-309
4. de Haan L, Weisfeit M, Dingemans PMAJ, Linszen DH, Wouters L: Psychometric properties of the Subjective Well-Being Under Neuroleptics Scale (SWN) and the Subjective Deficit Syndrome Scale (SDSS). Psychopharmacology 2002; 162:24-28